[Thailand Dhanura Success Story] From Struggles in Japan to Breakthrough at Dhanura Thailand
![[Thailand Dhanura Success Story] From Struggles in Japan to Breakthrough at Dhanura Thailand](https://cdn.yun.sooce.cn/6/59417/jpg/1748415531859f6aade71c623d86b7457930f1eaf5f7e.jpg?version=1748415547)
'In Japan, two cycles yielded 22 retrieved oocytes but only 3 mature ones! This time: 8 retrieved → 6 mature — maturity rate soared from 13.6% to 75%. So relieved we transferred here!' Comparative data between Japanese and Thai cycles.
'In Japan, two cycles yielded 22 retrieved oocytes but only 3 mature ones! This time: 8 retrieved → 6 mature — maturity rate soared from 13.6% to 75%. So relieved we transferred here!'

Comparative data between Japanese and Thai cycles
Basic Information
Female age: 41 years
Blood type: O positive (Rh+)
AMH: 1.46 ng/mL (range: 0.8–2.3)
Antral follicle count (AFC): ≥10
Menstrual cycle: Generally regular (26–28 days), occasionally prolonged
Past medical history / allergies / family genetic disorders: None
From 'Oocyte Producer' to 'Mature-Oocyte Hunter'
The Japanese Dilemma: The Overlooked 'Maturity Trap'
First Japanese cycle (July 2024): 8 follicles → 3 oocytes retrieved (including 1 MI immature oocyte) → 1 blastocyst (not PGT-A tested)
Second Japanese cycle (November 2024): 14 follicles → 3 mature oocytes (maturity rate: 21.4%) → 2 blastocysts (1 PGT-A tested and confirmed euploid)

Dhanura Thailand Breakthrough: A Shift from Quantity to Quality
Initial consultation at Dhanura Thailand (February 2025): Physician identified the key issue — 'Your AFC (≥10) is not poor, but oocyte maturation disorder is the primary factor.'
Dr. Xue’s strategy: 'There is room for improvement in ovarian stimulation — adopting the PPOS protocol to enhance oocyte maturity rate.'
Technical breakdown: How Dhanura achieved a 5-fold increase in maturity rate?
Three-Stage Maturity Management
Pre-treatment phase (prior to February 16, before arrival in Thailand): No pre-treatment required per physician assessment.
Stimulation phase (February 16–25)
Core elements of the PPOS protocol:
• Gradual stimulation: Starting dose of Gonal-F® 150 IU, increased to 225 IU later in the cycle
• Dydrogesterone to suppress premature LH surge (preventing premature ovulation)
• Addition of Cetrotide® 0.25 mg (GnRH antagonist) in mid-to-late stimulation phase
Oocyte retrieval phase (February 23–27)
Embryo culture and PGT-A screening




ICSI fertilization: All 6 mature oocytes successfully fertilized
Blastocyst formation: 3 blastocysts obtained (2 on Day 5, 1 on Day 6)
PGT-A chromosomal screening result: Euploid 5BB blastocyst (Day 5)

Key developmental milestones
MII oocytes: Only metaphase II (MII) oocytes possess fertilization competence
Cleavage synchrony: All Day-3 embryos were 8-cell stage, indicating consistent developmental potential
5BB blastocyst: '5' denotes degree of expansion; 'BB' indicates inner cell mass (ICM) and trophectoderm (TE) grading
Cross-border cycle: Shanghai–Bangkok 'Miracle Timeline' completed in just 9 days
Feb 16: Menstruation onset in Shanghai; PPOS protocol initiated
Feb 21: Transvaginal ultrasound at a top-tier Shanghai hospital: 7 follicles measuring 13–16 mm; E2 = 2150 pg/mL (indicating excellent follicular maturity)
Feb 23: Departure from Shanghai Pudong International Airport → Suvarnabhumi Airport, Bangkok; dedicated Dhanura Thailand staff met guest at airport and escorted to hotel; Dr. Xue monitored real-time updates on guest’s airport arrival and hotel check-in
Feb 24: Pre-retrieval follow-up consultation with Dr. Jariya at Dhanura Thailand
Feb 25: 'Oocyte protection' injection administered at Dhanura Thailand, based on follow-up findings
Feb 26: 'Trigger shot' (hCG or GnRH agonist) administered at Dhanura Thailand
Feb 27: Oocyte retrieval at Dhanura Thailand: 8 oocytes retrieved → 6 MII → ICSI performed on the same day
Expert Insight: Mature oocyte rate matters more than total oocyte count
Dr. Xue, Embryologist at Dhanura Thailand: 'For women over 40, the ovary resembles an 'aging orchard.' Rather than harvesting 10 green apples, it’s far better to wait for 3 ripe ones. Through precise hormonal modulation and rigorous maturity monitoring, we ensure each follicle reaches optimal maturity — 'fruit ripens and detaches naturally' at precisely the right moment.'
Medical Evaluation
For a 41-year-old woman with low AMH and limited ovarian reserve, this cycle represents a high-quality ovarian stimulation outcome. ICSI fertilization rate: 100%; blastocyst formation rate: 50%; one euploid blastocyst confirmed by PGT-A — clinically suitable for embryo transfer. Cycle management was highly efficient; cross-border patient journey was seamless; timing of trigger injection and ultrasound monitoring was well-coordinated.
This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.
Key Facts
- ▸A 41-year-old woman improved her oocyte maturation rate from 13.6% to 75% through the PPOS protocol in Thailand Danruo.
- ▸In Japan, only 3 mature oocytes were obtained from two cycles, while 6 mature oocytes were achieved in the Thailand Danruo cycle.
- ▸Through hormone regulation and maturity monitoring, Danruo helped the patient obtain one PGT-normal blastocyst.
- ▸The patient completed the entire process from Shanghai to Bangkok, including stimulation, egg retrieval, and embryo culture, in just 9 days.
- ▸Dr. Xue emphasized that the maturity rate of oocytes is more important than the number of eggs retrieved, focusing on the optimal time for each follicle to mature.
